Oral Answers to Questions

Gareth Thomas Excerpts

Thursday 10th June 2021 Commons Chamber

[Elizabeth Truss]

I am very proud that the UK Government funded research into the Oxford-AstraZeneca vaccine, which is now producing 98% of the 49 million covid vaccines delivered right around the world. We have played a leading role in that. I am interested in practical measures that have real effect, such as voluntary licensing agreements. If there is any evidence that intellectual property waivers could help, I am all ears and interested to hear it, but we cannot have a regime that destroys intellectual property rights and ends up stopping future innovation.

[Gareth Thomas (Harrow West) (Lab/Co-op)]

With all due respect to the Secretary of State, boosting the overall global supply of vaccines is key to get global trade going, secure British jobs and help our allies in the Commonwealth and the developing world. In these exceptional times, why did Britain, as my hon. Friend the Member for Portsmouth South (Stephen Morgan) said, refuse to support at the World Trade Organisation yesterday—presumably on the Secretary of State’s instruction—allies of ours such as America, India and South Africa, and many other countries, and to back a temporary waiver of patents on covid vaccines?

[Elizabeth Truss]

As I have said, the UK is always willing to listen to pragmatic suggestions about how we make the regime work better. For example, we have supported the abolition of export restrictions—many other countries have not—so that we can see goods flow around the world. The fact is that the real changes are being made by voluntary licensing, as we have enabled at the Serum Institute in India. We are part of the third-way work to roll out practical answers. There is no IP waiver proposal on the table that would actually deliver more vaccines to the poorest people in the world, which is what we want to achieve.